Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Beta Bionics Inc's Competitiveness

Name: Beta Bionics Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Beta Bionics Inc (BBNX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026

Competitors Tracked

Publicly traded peers

Peer Group Market Share

100.00 %

vs 100.00 % a year ago

Revenue Growth Y/Y

42.26 %

Q2 2026

Net Margin

-73.10 %

Q2 2026

Key Findings: Beta Bionics Inc vs Its Competitors

TTM: Trailing 12-month revenue of 120M vs -M combined for tracked competitors (100.0% combined share).
Trending: Latest-quarter revenue run-rate is accelerating (+7.1% annualized vs trailing 12 months).
Scale: Beta Bionics Inc ranks #76 of 247 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.1% of industry market cap.
Peer revenue share: Beta Bionics Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

BBNX Sales vs. its Competitors, Q2 2026

Beta Bionics Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/BBNX/competitors                    

                        https://api.csimarket.com/api/v1/companies/BBNX/relationships                    

                        https://api.csimarket.com/api/v1/companies/BBNX/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

For context: the Medical Equipment & Supplies industry grew revenue 15.0% year over year, combined, vs 42.3% for Beta Bionics Inc. Beta Bionics Inc's share of combined industry revenue moved from 0.02% to 0.03%, a gain of 0.01 percentage points.

Beta Bionics Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Beta Bionics Inc	No	-	-	Yes
Similar-Size Competitors (10)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

BBNX Stock Performance relative to its Competitors

BBNX Competitors (weighted) Percent change over the selected range

Beta Bionics Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

Similar-Size
(7 of 10)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Beta Bionics Inc	5.10 %	Underperformed
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (0)	40.4%	63.2%
Similar-Size Competitors (10)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Beta Bionics Inc's competitor groups requires a Commercial License.

Unlock Commercial Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

BBNX Stock Performance relative to Similar-Size Competitors

BBNX Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Beta Bionics Inc's Comment on Competition and Industry Peers

The competitive landscape includes competing with other treatment options based on availability, perceived advantages, relative cost, safety, and effectiveness. Emerging competing technologies and adverse market developments necessitate enhancements to existing products or the development of new products to maintain market share. Competition also influences patient enrollment in clinical trials, as patients may opt to participate in trials of competitor products. Additionally, regulatory pathways and potential third-party actions can affect the timing and approval of product candidates, impacting competitive positioning.